Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Neoadjuvant therapy for NSCLC: From monotherapy to precision combination therapy.

The CheckMate-816 trial confirmed that nivolumab plus chemotherapy outperforms chemotherapy alone, but there are still several challenges in neoadjuvant therapy.

Qianshuo Mao, H. Mo, Kai-Shan Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.